Cytosorbents CEO Phillip Chan's 2019 pay rises 13% to $1.4M
Cytosorbents reports 2019 executive compensation
By ExecPay News
Published: April 20, 2020
Cytosorbents reported fiscal year 2019 executive compensation information on April 20, 2020.
In 2019, three executives at Cytosorbents received on average a compensation package of $1.2M, a 9% increase compared to previous year.
Average pay of disclosed executives at Cytosorbents
Phillip P. Chan, Chief Executive Officer, received $1.4M in total, which increased by 13% compared to 2018. 34% of Chan's compensation, or $484K, was in stock awards. Chan also received $100K in bonus, $371K in option awards, $438K in salary, as well as $12K in other compensation.
Vincent J. Capponi, Chief Operating Officer, received a compensation package of $1.2M, which increased by 8% compared to previous year. 37% of the compensation package, or $434K, was in stock awards.
Kathleen P. Bloch, Chief Financial Officer, earned $1M in 2019, a 5% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 20, 2020.